GBA
MACK
Garrison Bradford & Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-87,700
| Closed | -$109K | – | 88 |
|
2017
Q2 | $109K | Hold |
87,700
| – | – | 0.09% | 78 |
|
2017
Q1 | $270K | Buy |
87,700
+10,000
| +13% | +$30.8K | 0.24% | 58 |
|
2016
Q4 | $317K | Sell |
77,700
-5,000
| -6% | -$20.4K | 0.29% | 55 |
|
2016
Q3 | $525K | Hold |
82,700
| – | – | 0.49% | 39 |
|
2016
Q2 | $446K | Hold |
82,700
| – | – | 0.44% | 42 |
|
2016
Q1 | $692K | Hold |
82,700
| – | – | 0.81% | 27 |
|
2015
Q4 | $653K | Hold |
82,700
| – | – | 0.73% | 31 |
|
2015
Q3 | $704K | Sell |
82,700
-8,000
| -9% | -$68.1K | 0.78% | 29 |
|
2015
Q2 | $1.12M | Hold |
90,700
| – | – | 1.1% | 22 |
|
2015
Q1 | $1.08M | Hold |
90,700
| – | – | 1.01% | 22 |
|
2014
Q4 | $1.03M | Sell |
90,700
-4,301
| -5% | -$48.6K | 0.93% | 25 |
|
2014
Q3 | $834K | Sell |
95,001
-3,000
| -3% | -$26.3K | 0.83% | 27 |
|
2014
Q2 | $714K | Hold |
98,001
| – | – | 0.66% | 37 |
|
2014
Q1 | $494K | Hold |
98,001
| – | – | 0.48% | 48 |
|
2013
Q4 | $522K | Hold |
98,001
| – | – | 0.49% | 43 |
|
2013
Q3 | $371K | Hold |
98,001
| – | – | 0.38% | 62 |
|
2013
Q2 | $661K | Buy |
+98,001
| New | +$661K | 0.71% | 35 |
|